BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ziakas PD, Zacharioudakis IM, Zervou FN, Grigoras C, Pliakos EE, Mylonakis E. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS One 2015;10:e0117195. [PMID: 25707002 DOI: 10.1371/journal.pone.0117195] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Benitez G, Shehadeh F, Kalligeros M, Mylona EK, Tran Q, Zacharioudakis IM, Mylonakis E. Risk Factors for Hospital Readmission for Clostridioides difficile Infection: A Statewide Retrospective Cohort Study. Pathogens 2022;11:555. [DOI: 10.3390/pathogens11050555] [Reference Citation Analysis]
2 Le Monnier A, Candela T, Mizrahi A, Bille E, Bourgeois-nicolaos N, Cattoir V, Farfour E, Grall I, Lecointe D, Limelette A, Marcade G, Poilane I, Poupy P, Kansau I, Zahar J, Pilmis B, Hartmann C, Kazhalawi A, Lambert-bordes S, Bleunven S, Bedos Réanimation J, Greder-belan A, Rigaudeau S, Lecuyer H, Jousset A, Lebeaux D, Levy B, Rabate C, Collignon A, Batah J, Francois V, Sebbane G, Woerther P, Loggia G, Michon J, Verdon R, Samba D, Méar J, Guillard T, Nguyen Y, Banisadr F, Delmer A, Himberlin C, Diallo S, Furet I, Achouri B, Reksa A, Jouveshomme S, Menage E, Philippart F, Hadj-abdeslam M, Durand-gasselin B, Eveillard M, Kouatchet A, Schmidt A, Salanoubat C, Heurtaux M, Cronier P, Foufa A. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals. Journal of Hospital Infection 2022. [DOI: 10.1016/j.jhin.2022.05.011] [Reference Citation Analysis]
3 Kullin B, Abratt VR, Reid SJ, Riley TV. Clostridioides difficile infection in Africa: A narrative review. Anaerobe 2022;:102549. [PMID: 35337974 DOI: 10.1016/j.anaerobe.2022.102549] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Luo Y, Zhang S, Shang H, Cui W, Wang Q, Zhu B. Prevalence of Clostridium difficile Infection in the Hematopoietic Transplantation Setting: Update of Systematic Review and Meta-Analysis. Front Cell Infect Microbiol 2022;12:801475. [DOI: 10.3389/fcimb.2022.801475] [Reference Citation Analysis]
5 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 36] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rodríguez-Villodres Á, Martín-Gandul C, Peñalva G, Guisado-Gil AB, Crespo-Rivas JC, Pachón-Ibáñez ME, Lepe JA, Cisneros JM. Prevalence and Risk Factors for Multidrug-Resistant Organisms Colonization in Long-Term Care Facilities Around the World: A Review. Antibiotics (Basel) 2021;10:680. [PMID: 34200238 DOI: 10.3390/antibiotics10060680] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211016248. [PMID: 34093740 DOI: 10.1177/17562848211016248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Felsen CB, Dodds Ashley ES, Barney GR, Nelson DL, Nicholas JA, Yang H, Aydelotte ME, Karlic A, Nicholas NC, Petrone KK, Pine RD, Schabel SL, Medina-Walpole A, Dumyati GK. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration. J Am Med Dir Assoc 2020;21:55-61.e2. [PMID: 31888865 DOI: 10.1016/j.jamda.2019.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
9 Shen Y, Ellison J, Leal J, Bush KR, Chandran AU, Fathima S, Conly JM. The use of laboratory-identified event surveillance to classify adverse outcomes due to Clostridioides difficile infection in Canadian long-term care facilities. Infect Control Hosp Epidemiol 2021;42:557-64. [PMID: 33222722 DOI: 10.1017/ice.2020.1269] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Couturier J, Franconeri L, Janoir C, Ferraris L, Syed-Zaidi R, Youssouf A, Gateau C, Hoys S, Aires J, Barbut F. Characterization of Non-Toxigenic Clostridioides difficile Strains Isolated from Preterm Neonates and In Vivo Study of Their Protective Effect. J Clin Med 2020;9:E3650. [PMID: 33202811 DOI: 10.3390/jcm9113650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Goltsman G, Gal G, Mizrahi EH, Mardanov S, Pinco E, Lubart E. The impact of intensive staff education on rate of Clostridium difficile-associated disease in hospitalized geriatric patients. Aging Clin Exp Res 2020;32:2393-8. [PMID: 31776858 DOI: 10.1007/s40520-019-01424-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Leitner E, Schreiner E, Neuhold M, Bozic M, Pux C, Pichler G, Schippinger W, Steinmetz I, Krause R, Zollner-Schwetz I. Low prevalence of Clostridium difficile colonization in patients in long-term care facilities in Graz, Austria: A point-prevalence study. Am J Infect Control 2020;48:1144-7. [PMID: 31917013 DOI: 10.1016/j.ajic.2019.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Ahmed A. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005–2014. Dig Dis Sci 2021;66:296-307. [DOI: 10.1007/s10620-020-06162-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 McConeghy KW, Zullo AR, Lary CW, Zhang T, Lee Y, Daiello L, Kiel DP, Berry S. Association Between Bisphosphonates and Hospitalized Clostridioides difficile Infection Among Frail Older Adults. J Am Med Dir Assoc 2020;21:688-91. [PMID: 31932139 DOI: 10.1016/j.jamda.2019.11.016] [Reference Citation Analysis]
15 . Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI): Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsbl 2019;62:906-23. [DOI: 10.1007/s00103-019-02959-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
16 Li GJ, Trac J, Husain S, Famure O, Li Y, Kim SJ. Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients. Transplantation 2018;102:1576-81. [PMID: 29620613 DOI: 10.1097/TP.0000000000002199] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Quigley L, Coakley M, Alemayehu D, Rea MC, Casey PG, O'Sullivan Ó, Murphy E, Kiely B, Cotter PD, Hill C, Ross RP. Lactobacillus gasseri APC 678 Reduces Shedding of the Pathogen Clostridium difficile in a Murine Model. Front Microbiol 2019;10:273. [PMID: 30842760 DOI: 10.3389/fmicb.2019.00273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Zacharioudakis IM, Zervou FN, Shehadeh F, Mylona EK, Mylonakis E. Association of Community Factors with Hospital-onset Clostridioides (Clostridium) difficile Infection: A Population Based U.S.-wide Study. EClinicalMedicine 2019;8:12-9. [PMID: 31193719 DOI: 10.1016/j.eclinm.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sheth PM, Douchant K, Uyanwune Y, Larocque M, Anantharajah A, Borgundvaag E, Dales L, McCreight L, McNaught L, Moore C, Ragan K, McGeer A, Broukhanski G. Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital. PLoS One 2019;14:e0207138. [PMID: 30742636 DOI: 10.1371/journal.pone.0207138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
20 Chamchod F, Palittapongarnpim P. Modeling Clostridium difficile in a hospital setting: control and admissions of colonized and symptomatic patients. Theor Biol Med Model 2019;16:2. [PMID: 30704484 DOI: 10.1186/s12976-019-0098-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kullin BR, Reid S, Abratt V. Clostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014-2015. Afr J Lab Med 2018;7:846. [PMID: 30568907 DOI: 10.4102/ajlm.v7i2.846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Fuchs BB, Tharmalingam N, Mylonakis E. Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions. Future Microbiol 2018;13:1537-47. [PMID: 30311778 DOI: 10.2217/fmb-2018-0157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Luk S, Ho AYM, Chan EHY, Tsang IHL, Ng TK, To WK, Choi KW, Wong ATY. High Prevalence and Frequent Acquisition of Clostridium difficile Ribotype 002 Among Nursing Home Residents in Hong Kong. Infect Control Hosp Epidemiol 2018;39:782-7. [PMID: 29733004 DOI: 10.1017/ice.2018.92] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Collins J, Auchtung JM. Control of Clostridium difficile Infection by Defined Microbial Communities. Microbiol Spectr 2017;5. [PMID: 28936948 DOI: 10.1128/microbiolspec.BAD-0009-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
25 Araos R, Andreatos N, Ugalde J, Mitchell S, Mylonakis E, D'Agata EMC. Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile. Dig Dis Sci 2018;63:1525-31. [PMID: 29594967 DOI: 10.1007/s10620-018-5030-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
26 Crobach MJT, Vernon JJ, Loo VG, Kong LY, Péchiné S, Wilcox MH, Kuijper EJ. Understanding Clostridium difficile Colonization. Clin Microbiol Rev 2018;31:e00021-17. [PMID: 29540433 DOI: 10.1128/CMR.00021-17] [Cited by in Crossref: 86] [Cited by in F6Publishing: 108] [Article Influence: 21.5] [Reference Citation Analysis]
27 Zheng Y, Luo Y, Lv Y, Huang C, Sheng Q, Zhao P, Ye J, Jiang W, Liu L, Song X, Tong Z, Chen W, Lin J, Tang YW, Jin D, Fang W. Clostridium difficile colonization in preoperative colorectal cancer patients. Oncotarget 2017;8:11877-86. [PMID: 28060753 DOI: 10.18632/oncotarget.14424] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
28 Jump RLP, Gaur S, Katz MJ, Crnich CJ, Dumyati G, Ashraf MS, Frentzel E, Schweon SJ, Sloane P, Nace D; Infection Advisory Committee for AMDA—The Society of Post-Acute and Long-Term Care Medicine. Template for an Antibiotic Stewardship Policy for Post-Acute and Long-Term Care Settings. J Am Med Dir Assoc 2017;18:913-20. [PMID: 28935515 DOI: 10.1016/j.jamda.2017.07.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
29 Zainul NH, Ma ZF, Besari A, Siti Asma H, Rahman RA, Collins DA, Hamid N, Riley TV, Lee YY. Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia. Epidemiol Infect 2017;145:3012-9. [PMID: 28891459 DOI: 10.1017/S0950268817002011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
30 Roghmann MC, Andronescu LR, Stucke EM, Johnson JK. Clostridium difficile Colonization of Nursing Home Residents. Infect Control Hosp Epidemiol 2017;38:1267-8. [PMID: 28826425 DOI: 10.1017/ice.2017.172] [Reference Citation Analysis]
31 White DR, Hamilton KW, Pegues DA, Hanish A, Umscheid CA. The Impact of a Computerized Clinical Decision Support Tool on Inappropriate Clostridium difficile Testing. Infect Control Hosp Epidemiol 2017;38:1204-8. [DOI: 10.1017/ice.2017.161] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
32 Behar L, Chadwick D, Dunne A, Jones CI, Proctor C, Rajkumar C, Sharratt P, Stanley P, Whiley A, Wilks M, Llewelyn MJ. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival. J Infect 2017;75:20-5. [PMID: 28435086 DOI: 10.1016/j.jinf.2017.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
33 Joyce NR, Mylonakis E, Mor V. Effect of Clostridium difficile Prevalence in Hospitals and Nursing Homes on Risk of Infection. J Am Geriatr Soc 2017;65:1527-34. [PMID: 28394408 DOI: 10.1111/jgs.14838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Dumyati G, Stone ND, Nace DA, Crnich CJ, Jump RL. Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing Homes. Curr Infect Dis Rep 2017;19:18. [PMID: 28382547 DOI: 10.1007/s11908-017-0576-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 9.4] [Reference Citation Analysis]
35 Blixt T, Gradel KO, Homann C, Seidelin JB, Schønning K, Lester A, Houlind J, Stangerup M, Gottlieb M, Knudsen JD. Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients. Gastroenterology 2017;152:1031-1041.e2. [PMID: 28063955 DOI: 10.1053/j.gastro.2016.12.035] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
36 Jacob J, Wu J, Han J, Nelson DB. Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital. Infect Control Hosp Epidemiol 2017;38:294-9. [PMID: 27923419 DOI: 10.1017/ice.0000-0.291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Nissle K, Kopf D, Rösler A. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients. BMC Geriatr 2016;16:185. [PMID: 27846818 DOI: 10.1186/s12877-016-0358-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
38 van Kleef E, Deeny SR, Jit M, Cookson B, Goldenberg SD, Edmunds WJ, Robotham JV. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine 2016;34:5562-70. [DOI: 10.1016/j.vaccine.2016.09.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
39 Olanipekun TO, Salemi JL, Mejia de Grubb MC, Gonzalez SJ, Zoorob RJ. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care. Diabetes Res Clin Pract 2016;116:68-79. [PMID: 27321318 DOI: 10.1016/j.diabres.2016.04.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primers 2016;2:16020. [PMID: 27158839 DOI: 10.1038/nrdp.2016.20] [Cited by in Crossref: 301] [Cited by in F6Publishing: 316] [Article Influence: 50.2] [Reference Citation Analysis]
41 Martin JSH, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol 2016;13:206-16. [DOI: 10.1038/nrgastro.2016.25] [Cited by in Crossref: 196] [Cited by in F6Publishing: 175] [Article Influence: 32.7] [Reference Citation Analysis]
42 Rodriguez C, Taminiau B, Van Broeck J, Delmée M, Daube G. Clostridium difficile infection and intestinal microbiota interactions. Microb Pathog 2015;89:201-9. [PMID: 26549493 DOI: 10.1016/j.micpath.2015.10.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]